85 related articles for article (PubMed ID: 2222834)
1. Cold-adapted influenza viruses for use as live vaccines for man.
Maassab HF; Heilman CA; Herlocher ML
Adv Biotechnol Processes; 1990; 14():203-42. PubMed ID: 2222834
[No Abstract] [Full Text] [Related]
2. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.
Murphy BR; Coelingh K
Viral Immunol; 2002; 15(2):295-323. PubMed ID: 12081014
[No Abstract] [Full Text] [Related]
3. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist).
Chen Z; Aspelund A; Kemble G; Jin H
Virology; 2006 Feb; 345(2):416-23. PubMed ID: 16289204
[TBL] [Abstract][Full Text] [Related]
4. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
Talon J; Salvatore M; O'Neill RE; Nakaya Y; Zheng H; Muster T; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4309-14. PubMed ID: 10725408
[TBL] [Abstract][Full Text] [Related]
5. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).
Cox NJ; Kitame F; Kendal AP; Maassab HF; Naeve C
Virology; 1988 Dec; 167(2):554-67. PubMed ID: 2974219
[TBL] [Abstract][Full Text] [Related]
6. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
7. Vaccines. Shifting tactics in the battle against influenza.
Ault A
Science; 2004 Feb; 303(5662):1280. PubMed ID: 14988531
[No Abstract] [Full Text] [Related]
8. Influenza vaccines.
Brede HD
Int Arch Allergy Immunol; 1995 Dec; 108(4):318-20. PubMed ID: 7580301
[TBL] [Abstract][Full Text] [Related]
9. [Influenza activity in China from 2000 to 2001].
Zhang Y; Li Z; Guo JF; Wang M; Wen LY; Guo YJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):4-8. PubMed ID: 12678953
[TBL] [Abstract][Full Text] [Related]
10. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
11. [The prospects for using inactivated influenza vaccines on the troops].
Furgal SM; Degtiarev AA; Korol'kov VF
Voen Med Zh; 1993 May; (5):35-6, 80. PubMed ID: 8356819
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
13. Learning from our foes: a novel vaccine concept for influenza virus.
Palese P; Muster T; Zheng H; O'Neill R; Garcia-Sastre A
Arch Virol Suppl; 1999; 15():131-8. PubMed ID: 10470274
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated vaccines against influenza; an historical review.
Wareing MD; Tannock GA
Vaccine; 2001 May; 19(25-26):3320-30. PubMed ID: 11348696
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a live attenuated influenza B virus vaccine candidate.
Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
[TBL] [Abstract][Full Text] [Related]
16. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
[No Abstract] [Full Text] [Related]
17. A review of attenuation of influenza viruses by genetic manipulation.
Belshe RB
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S72-5. PubMed ID: 7551418
[No Abstract] [Full Text] [Related]
18. [The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].
El'shina GA; Masalin IuM; Shervali VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
Voen Med Zh; 1996 Aug; 317(8):57-60. PubMed ID: 9036650
[No Abstract] [Full Text] [Related]
19. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
